- This topic is empty.
-
Posts
-
The CurePSP Biomarker Accelerator Program is accepting LOIs through December 15th.
Complete program information and application instructions are available here: https://www.psp.org/biomarker-accelerator-application
Program Overview:
The Biomarker Accelerator Program will fund projects driving biomarker discoveries to accelerate diagnosis, treatment, research, or clinical care for progressive supranuclear palsy (PSP_. The proposed studies should build upon existing discoveries by conducting the next steps needed to move the biomarkers into research or clinical settings. The existing discoveries may come from preclinical models, fluids, tissue, proteomics, imaging, genetic data, or other modalities. Projects can propose to further validate/replicate these findings, develop assays or tools, integrate biomarkers of different modalities, or other approaches that will advance biomarker development for PSP. While diagnostic biomarkers are a primary goal of this program, we will accept proposals focused on any context of use that will further research or clinical care for PSP. Please see the Application Instructions for a list of eligible and ineligible topics for this program.
Program Eligibility:
The CurePSP Biomarker Accelerator Program is open to researchers at academic institutions and researchers at small companies (nonprofits and for-profit organizations). Partnership between academia and larger companies is allowed. Investigators can be located in the U.S. or internationally. The Principal Investigator of the project must be a full-time faculty member or paid employee of the organization submitting the proposal. If the applicant is not a paid employee, they must demonstrate that they are part of the company and a listed employee. Applications from post-doctoral researchers will not be accepted. Current awardees of CurePSP are eligible, provided their other funded grant does not directly overlap with this proposal.
Award Overview:
The Biomarker Accelerator Program will fund each award up to $500,000 for the duration of the project. No indirect costs are allowed for this program. The proposed award term can be up to three years. Budget spending should appropriately align to the award length, specific aims and proposed milestones of the project. Please see the Application Instructions for more detailed information on allowable expenses.
Timeline:
- Letter of Intent Launch: October 15, 2026
- Letter of Intent Deadline: December 15, 2026, 5:00 PM US Eastern Time
- Letter of Intent Decision Notification: By January 31, 2027
- Full Proposal Deadline: March 31, 2027, 5:00 PM US Eastern Time
- You must be logged in to reply to this topic.